| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX006 (ip) | median tumor weight (est.) | saline | 24.0 mg/kg/injection | 9.0 | Antitumor endpoint evaluated on day 23; 07/09 animals surviving on tox evaluation day (usually day 5) |
| Q01DX006 (ip) | median tumor weight (est.) | saline | 36.0 mg/kg/injection | 7.0 | Antitumor endpoint evaluated on day 23; 08/10 animals surviving on tox evaluation day (usually day 5) |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 8.7 mg/kg/injection | 11.0 | Antitumor endpoint evaluated on day 20; 09/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 8.7 mg/kg/injection | 176.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 8.7 mg/kg/injection | 84.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 8.7 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 20; 09/09 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 8.7 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 8.7 mg/kg/injection | 79.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 8.75 mg/kg/injection | 59.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 17.5 mg/kg/injection | 55.0 | Antitumor endpoint evaluated on day 20; 09/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 17.5 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 17.5 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 17.5 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 17.5 mg/kg/injection | 165.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 17.5 mg/kg/injection | 36.0 | Antitumor endpoint evaluated on day 20; 09/09 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 17.5 mg/kg/injection | 33.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 35.0 mg/kg/injection | 30.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 35.0 mg/kg/injection | 44.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 35.0 mg/kg/injection | 33.0 | Antitumor endpoint evaluated on day 20; 08/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 35.0 mg/kg/injection | 120.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 35.0 mg/kg/injection | 58.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 35.0 mg/kg/injection | 72.0 | Antitumor endpoint evaluated on day 20; 09/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 35.0 mg/kg/injection | 33.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 70.0 mg/kg/injection | 16.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 70.0 mg/kg/injection | 1.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 70.0 mg/kg/injection | 24.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 70.0 mg/kg/injection | 32.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 70.0 mg/kg/injection | 47.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 70.0 mg/kg/injection | 29.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 70.0 mg/kg/injection | 38.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 140.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 02/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 140.0 mg/kg/injection | 3.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 140.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 02/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 140.0 mg/kg/injection | 4.0 | Antitumor endpoint evaluated on day 20; 09/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 140.0 mg/kg/injection | 4.0 | Antitumor endpoint evaluated on day 20; 08/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 140.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 06/10 animals surviving on day 20 |
| Q07DX002 (ip) | median tumor weight (est.) | saline | 140.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 05/10 animals surviving on day 20 |
| Q07DX002 (ip) | optimum tumor weight change | saline | 35.0 mg/kg/injection | 48.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 35 |
| Q07DX002 (ip) | optimum tumor weight change | saline | 70.0 mg/kg/injection | 46.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 35 |
| Q07DX002 (ip) | optimum tumor weight change | saline | 140.0 mg/kg/injection | 45.0 | Antitumor endpoint evaluated on day 60; 09/10 animals surviving on day 35 |